Preticks
.
Follow Us
News Details
MyoKardia and Fulcrum Therapeutics Announce Multi-Target Collaboration to Discover Novel Targeted Therapies for Genetic Cardiomyopathies
About Fulcrum Therapeutics, Inc.
NASDAQ: $FULC
Notified: $17.78
07:30 EDT
Price Chart